Sanford C. Bernstein Issues Pessimistic Forecast for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies (NYSE:A) had its target price dropped by equities research analysts at Sanford C. Bernstein from $140.00 to $135.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “market perform” rating on the medical research company’s stock. Sanford C. Bernstein’s target price points to a potential downside of 2.25% from the stock’s current price.

A has been the subject of a number of other research reports. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday. Bank of America lifted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. TD Cowen raised their target price on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Wells Fargo & Company began coverage on Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective for the company. Finally, Evercore ISI boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $143.40.

Agilent Technologies Stock Performance

A opened at $138.11 on Tuesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The business has a fifty day simple moving average of $137.72 and a 200 day simple moving average of $137.43. Agilent Technologies has a 1 year low of $124.10 and a 1 year high of $155.35. The company has a market capitalization of $39.68 billion, a PE ratio of 31.25, a price-to-earnings-growth ratio of 5.91 and a beta of 1.07.

Insider Buying and Selling

In other news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Institutional Investors Weigh In On Agilent Technologies

Several institutional investors have recently bought and sold shares of A. Ancora Advisors LLC boosted its stake in shares of Agilent Technologies by 4.0% in the 1st quarter. Ancora Advisors LLC now owns 7,226 shares of the medical research company’s stock worth $1,051,000 after buying an additional 275 shares during the last quarter. B. Riley Wealth Advisors Inc. grew its stake in Agilent Technologies by 47.9% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock valued at $768,000 after purchasing an additional 1,711 shares during the period. California State Teachers Retirement System increased its position in shares of Agilent Technologies by 1.2% during the 1st quarter. California State Teachers Retirement System now owns 475,029 shares of the medical research company’s stock valued at $69,121,000 after purchasing an additional 5,543 shares during the last quarter. Tidal Investments LLC raised its stake in shares of Agilent Technologies by 58.2% during the 1st quarter. Tidal Investments LLC now owns 17,447 shares of the medical research company’s stock worth $2,540,000 after purchasing an additional 6,420 shares during the period. Finally, iA Global Asset Management Inc. boosted its holdings in shares of Agilent Technologies by 26.2% in the 1st quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock worth $3,168,000 after buying an additional 4,523 shares during the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.